 Von Samedi
Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pathologists | 1 | 2021 | 19 | 0.650 |
Why?
| | Minority Groups | 1 | 2021 | 285 | 0.560 |
Why?
| | Head and Neck Neoplasms | 4 | 2024 | 561 | 0.540 |
Why?
| | Abdominal Pain | 2 | 2015 | 149 | 0.490 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2017 | 138 | 0.460 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2017 | 228 | 0.430 |
Why?
| | Pancreatitis | 1 | 2015 | 146 | 0.400 |
Why?
| | Endovascular Procedures | 1 | 2017 | 390 | 0.360 |
Why?
| | Celiac Disease | 1 | 2015 | 311 | 0.340 |
Why?
| | Ascites | 2 | 2014 | 48 | 0.340 |
Why?
| | Mesothelioma | 1 | 2010 | 52 | 0.310 |
Why?
| | Peritoneal Neoplasms | 1 | 2010 | 104 | 0.300 |
Why?
| | Thy-1 Antigens | 2 | 2020 | 11 | 0.300 |
Why?
| | Biopsy | 4 | 2020 | 1082 | 0.290 |
Why?
| | Down Syndrome | 1 | 2015 | 525 | 0.270 |
Why?
| | B7-H1 Antigen | 2 | 2020 | 244 | 0.250 |
Why?
| | Crohn Disease | 2 | 2020 | 260 | 0.220 |
Why?
| | Nose Neoplasms | 1 | 2025 | 22 | 0.220 |
Why?
| | Carcinosarcoma | 1 | 2025 | 23 | 0.220 |
Why?
| | Teratoma | 1 | 2025 | 124 | 0.200 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2024 | 40 | 0.200 |
Why?
| | Mouth Neoplasms | 1 | 2023 | 90 | 0.190 |
Why?
| | Prisoners | 1 | 2025 | 142 | 0.190 |
Why?
| | Ascitic Fluid | 2 | 2014 | 15 | 0.190 |
Why?
| | Larynx | 1 | 2023 | 56 | 0.190 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2023 | 76 | 0.180 |
Why?
| | Sentinel Lymph Node | 1 | 2022 | 49 | 0.180 |
Why?
| | Health Status Disparities | 1 | 2025 | 321 | 0.170 |
Why?
| | Th1 Cells | 2 | 2020 | 139 | 0.170 |
Why?
| | Tonsillar Neoplasms | 1 | 2020 | 10 | 0.160 |
Why?
| | Neoplasms, Unknown Primary | 1 | 2020 | 20 | 0.160 |
Why?
| | Palatine Tonsil | 1 | 2020 | 54 | 0.160 |
Why?
| | Gastrointestinal Stromal Tumors | 1 | 2020 | 41 | 0.150 |
Why?
| | Abscess | 1 | 2020 | 77 | 0.150 |
Why?
| | Recurrence | 2 | 2015 | 1139 | 0.150 |
Why?
| | Matrix Metalloproteinases | 1 | 2020 | 95 | 0.150 |
Why?
| | Radiosurgery | 1 | 2022 | 399 | 0.140 |
Why?
| | Tonsillectomy | 1 | 2020 | 105 | 0.140 |
Why?
| | Papillomavirus Infections | 1 | 2022 | 344 | 0.140 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 339 | 0.140 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2023 | 641 | 0.140 |
Why?
| | Angiomyolipoma | 1 | 2018 | 21 | 0.140 |
Why?
| | Intestinal Neoplasms | 1 | 2018 | 30 | 0.130 |
Why?
| | Healthcare Disparities | 1 | 2025 | 736 | 0.130 |
Why?
| | Stromal Cells | 1 | 2018 | 121 | 0.130 |
Why?
| | Tuberous Sclerosis | 1 | 2018 | 56 | 0.130 |
Why?
| | Aortography | 1 | 2017 | 52 | 0.130 |
Why?
| | Marfan Syndrome | 1 | 2017 | 46 | 0.130 |
Why?
| | Isoflavones | 2 | 2007 | 25 | 0.120 |
Why?
| | Blood Vessel Prosthesis | 1 | 2017 | 140 | 0.120 |
Why?
| | Colitis, Ulcerative | 1 | 2018 | 148 | 0.120 |
Why?
| | Diagnosis, Differential | 3 | 2015 | 1512 | 0.120 |
Why?
| | Neuroendocrine Tumors | 1 | 2018 | 119 | 0.120 |
Why?
| | Stomach Neoplasms | 1 | 2018 | 128 | 0.120 |
Why?
| | Computed Tomography Angiography | 1 | 2017 | 146 | 0.120 |
Why?
| | Cell Membrane | 1 | 2020 | 709 | 0.120 |
Why?
| | Hemochromatosis | 1 | 2015 | 9 | 0.110 |
Why?
| | Humans | 22 | 2025 | 145750 | 0.110 |
Why?
| | Duodenoscopy | 1 | 2015 | 8 | 0.110 |
Why?
| | Ferritins | 1 | 2015 | 70 | 0.110 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2015 | 90 | 0.110 |
Why?
| | Acute Disease | 2 | 2015 | 1036 | 0.110 |
Why?
| | Diet, Gluten-Free | 1 | 2015 | 56 | 0.110 |
Why?
| | Genistein | 2 | 2006 | 13 | 0.110 |
Why?
| | Fibroblasts | 1 | 2020 | 1027 | 0.100 |
Why?
| | Prostatic Neoplasms | 3 | 2007 | 981 | 0.100 |
Why?
| | Kidney Neoplasms | 1 | 2018 | 414 | 0.100 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2016 | 356 | 0.100 |
Why?
| | Colonic Neoplasms | 1 | 2015 | 258 | 0.100 |
Why?
| | Stents | 1 | 2017 | 564 | 0.100 |
Why?
| | Prednisone | 1 | 2014 | 226 | 0.090 |
Why?
| | Gastritis | 1 | 2014 | 117 | 0.090 |
Why?
| | Enteritis | 1 | 2014 | 105 | 0.090 |
Why?
| | Cholestasis | 1 | 2015 | 214 | 0.090 |
Why?
| | Antibodies, Neutralizing | 1 | 2015 | 340 | 0.090 |
Why?
| | Hepatitis C | 1 | 2015 | 256 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2015 | 457 | 0.090 |
Why?
| | Extracellular Matrix | 1 | 2016 | 562 | 0.090 |
Why?
| | Killer Cells, Natural | 1 | 2015 | 481 | 0.090 |
Why?
| | Eosinophilia | 1 | 2014 | 224 | 0.090 |
Why?
| | Treatment Outcome | 2 | 2017 | 11793 | 0.080 |
Why?
| | Patient Compliance | 1 | 2015 | 588 | 0.080 |
Why?
| | Macrophages | 2 | 2015 | 1507 | 0.080 |
Why?
| | Immunohistochemistry | 2 | 2015 | 1723 | 0.080 |
Why?
| | Peritoneum | 1 | 2010 | 43 | 0.080 |
Why?
| | Autopsy | 1 | 2010 | 94 | 0.080 |
Why?
| | Adult | 7 | 2020 | 40867 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2007 | 1450 | 0.080 |
Why?
| | Fatal Outcome | 1 | 2010 | 305 | 0.080 |
Why?
| | Glucocorticoids | 1 | 2014 | 532 | 0.080 |
Why?
| | Pancreatic Neoplasms | 1 | 2018 | 928 | 0.070 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2123 | 0.070 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 688 | 0.070 |
Why?
| | Colorectal Neoplasms | 1 | 2015 | 868 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2015 | 1997 | 0.060 |
Why?
| | Male | 10 | 2025 | 72992 | 0.060 |
Why?
| | Mice | 6 | 2024 | 18357 | 0.060 |
Why?
| | Phytoestrogens | 1 | 2006 | 17 | 0.060 |
Why?
| | Soybean Proteins | 1 | 2006 | 15 | 0.060 |
Why?
| | Androgens | 1 | 2007 | 181 | 0.060 |
Why?
| | Skin | 1 | 2010 | 754 | 0.060 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2024 | 1146 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2006 | 269 | 0.050 |
Why?
| | DNA Copy Number Variations | 1 | 2025 | 188 | 0.050 |
Why?
| | Inflammation | 1 | 2015 | 2883 | 0.050 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2023 | 25 | 0.050 |
Why?
| | Phosphatidylinositols | 1 | 2023 | 58 | 0.050 |
Why?
| | Female | 8 | 2023 | 79025 | 0.050 |
Why?
| | beta Catenin | 1 | 2025 | 254 | 0.050 |
Why?
| | Carcinogens | 1 | 2023 | 123 | 0.050 |
Why?
| | Steroids | 1 | 2023 | 160 | 0.040 |
Why?
| | Constriction, Pathologic | 1 | 2023 | 249 | 0.040 |
Why?
| | Gene Expression | 1 | 2007 | 1478 | 0.040 |
Why?
| | Anticarcinogenic Agents | 1 | 2002 | 63 | 0.040 |
Why?
| | Carcinogenesis | 1 | 2023 | 228 | 0.040 |
Why?
| | Lymph Node Excision | 1 | 2022 | 173 | 0.040 |
Why?
| | Animals | 6 | 2024 | 38100 | 0.040 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2023 | 189 | 0.040 |
Why?
| | Trachea | 1 | 2023 | 258 | 0.040 |
Why?
| | Tonsillitis | 1 | 2020 | 8 | 0.040 |
Why?
| | Unnecessary Procedures | 1 | 2020 | 54 | 0.040 |
Why?
| | Aged | 3 | 2023 | 26212 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2022 | 1270 | 0.040 |
Why?
| | Neoadjuvant Therapy | 1 | 2022 | 467 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2024 | 735 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2007 | 751 | 0.040 |
Why?
| | Cytokines | 2 | 2018 | 2069 | 0.040 |
Why?
| | Th17 Cells | 1 | 2020 | 102 | 0.040 |
Why?
| | Biomarkers, Tumor | 1 | 2025 | 1329 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 923 | 0.030 |
Why?
| | Immunotherapy | 1 | 2022 | 667 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2018 | 319 | 0.030 |
Why?
| | Germ-Line Mutation | 1 | 2018 | 177 | 0.030 |
Why?
| | Atrial Remodeling | 1 | 2016 | 10 | 0.030 |
Why?
| | Myofibroblasts | 1 | 2018 | 149 | 0.030 |
Why?
| | Health Services Accessibility | 1 | 2025 | 1101 | 0.030 |
Why?
| | Immunoblotting | 1 | 2016 | 295 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2016 | 365 | 0.030 |
Why?
| | Actins | 1 | 2018 | 427 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2018 | 2805 | 0.030 |
Why?
| | Pancreas | 1 | 2018 | 341 | 0.030 |
Why?
| | Phlebotomy | 1 | 2015 | 22 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2022 | 1505 | 0.030 |
Why?
| | Biopsy, Needle | 1 | 2015 | 185 | 0.030 |
Why?
| | Blood Chemical Analysis | 1 | 2015 | 109 | 0.030 |
Why?
| | Liver Failure | 1 | 2015 | 83 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2016 | 450 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2015 | 5992 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2018 | 1133 | 0.030 |
Why?
| | Mutation | 1 | 2025 | 4090 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2933 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2016 | 731 | 0.020 |
Why?
| | Ileum | 1 | 2014 | 112 | 0.020 |
Why?
| | Diarrhea | 1 | 2014 | 193 | 0.020 |
Why?
| | Tumor Cells, Cultured | 2 | 2006 | 887 | 0.020 |
Why?
| | Adolescent | 2 | 2025 | 22569 | 0.020 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 675 | 0.020 |
Why?
| | Middle Aged | 3 | 2018 | 36297 | 0.020 |
Why?
| | Kidney | 1 | 2018 | 1498 | 0.020 |
Why?
| | Proteomics | 1 | 2016 | 1188 | 0.020 |
Why?
| | Chronic Pain | 1 | 2014 | 291 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 481 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2601 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2770 | 0.020 |
Why?
| | Cyclin B | 1 | 2007 | 15 | 0.020 |
Why?
| | Forkhead Box Protein O3 | 1 | 2007 | 18 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2007 | 64 | 0.020 |
Why?
| | United States | 1 | 2025 | 16122 | 0.020 |
Why?
| | Biological Availability | 1 | 2007 | 145 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 106 | 0.020 |
Why?
| | Culture Media | 1 | 2007 | 161 | 0.020 |
Why?
| | Biomarkers | 1 | 2018 | 4302 | 0.020 |
Why?
| | Prostate-Specific Antigen | 1 | 2007 | 161 | 0.010 |
Why?
| | Forkhead Transcription Factors | 1 | 2007 | 209 | 0.010 |
Why?
| | Down-Regulation | 1 | 2007 | 618 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 2007 | 452 | 0.010 |
Why?
| | Up-Regulation | 1 | 2007 | 848 | 0.010 |
Why?
| | Cell Cycle | 1 | 2007 | 599 | 0.010 |
Why?
| | Emergency Service, Hospital | 1 | 2015 | 2383 | 0.010 |
Why?
| | Heart Failure | 1 | 2016 | 2326 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 2028 | 0.010 |
Why?
| | Transplantation, Heterologous | 1 | 2002 | 170 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2002 | 273 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 2002 | 246 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 14250 | 0.010 |
Why?
| | Cell Division | 1 | 2002 | 757 | 0.010 |
Why?
| | Mice, Nude | 1 | 2002 | 680 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2007 | 1454 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2007 | 1777 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2007 | 2514 | 0.010 |
Why?
| | DNA | 1 | 2006 | 1437 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 3551 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2002 | 630 | 0.010 |
Why?
|
|
Samedi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|